The Valley Desk

NCT05241873 · Interventional trial

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

Overall registry status Terminated

Phase 1

Conditions Adenocarcinoma, Antineoplastic Agents, Brain Metastases, Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, EGFR Activating Mutation, EGFR Atypical Mutations, Including G719X and L861Q, EGFR Exon 20 Insertion Mutation, EGFR Exon 20 Mutation, EGFR-mutated NSCLC, Lung Diseases, Lung Neoplasm Malignant, Metastatic Lung Cancer, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Respiratory Tract Disease, Respiratory Tract Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov